Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Brain Imaging

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Beyond Alzheimer's disease-translating biomarker insights across CNS diseases.

Science translational medicine·2025

Same author

Biomarker Methodologies: A NIMH Perspective.

Advances in neurobiology·2024

Same author

NIMH perspectives on future directions in neuroimaging for mental health.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2024

Same author

New directions in psychiatric drug development: promising therapeutics in the pipeline.

Expert opinion on drug discovery·2023

Same author

Accelerating Medicines Partnership<sup>®</sup> Schizophrenia (AMP<sup>®</sup> SCZ): developing tools to enable early intervention in the psychosis high risk state.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2023

Same author

Redirecting the revolution: new developments in drug development for psychiatry.

Expert opinion on drug discovery·2019

Search research articles

Related Experiment Video

Updated: May 11, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Assessing biomarkers for brain diseases: progress and gaps.

Linda S Brady¹

¹Division of Neuroscience and Basic Behavioral Science, National Institute of Mental Health, 6001 Executive Boulevard, Bethesda, MD 20892, USA.

Genome Medicine

|May 16, 2013

Summary

This conference report highlights the challenges and opportunities in identifying biomarkers for brain disorders. Experts discussed advancements and future directions in neurological disease research.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Related Experiment Videos

Last Updated: May 11, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Area of Science:

Neuroscience
Biomarker Discovery
Neurological Disorders

Background:

The 2nd Wellcome Trust Scientific Conference convened experts to address critical issues in biomarker development for brain disorders.
The conference focused on the complexities and potential breakthroughs in identifying reliable biomarkers for neurological conditions.

Purpose of the Study:

To summarize key discussions and outcomes from the 2013 Wellcome Trust conference on brain disorder biomarkers.
To outline the challenges and opportunities in the field of neurological biomarker research.

Main Methods:

The report is based on presentations and discussions from a scientific conference.
Expert insights and consensus on biomarker strategies were gathered.

Main Results:

Significant challenges remain in validating biomarkers for brain disorders, including heterogeneity and accessibility.
Opportunities lie in multi-modal approaches, advanced imaging, and 'omics' technologies for biomarker identification.

Conclusions:

Continued collaboration and technological innovation are crucial for advancing biomarker discovery in brain disorders.
Translating research findings into clinical practice requires addressing current limitations and embracing new methodologies.